The Psychedelics Research Group logo


The Psychedelic Research Group at Imperial focuses on two main research areas: 1) the action of psychedelic drugs in the brain, and 2) their clinical utility, e.g. as aides to psychotherapy, with a particular focus on depression. The group is lead by Dr Robin Carhart-Harris.

For news about our group's latest research and public presentations etc please see: http://psychedelicscience.org.uk

If you plan to take a psychedelic in the near future, please see this survey: https://psychedelicsurvey.com

For updates about the PsychedelicResearch Group's forthcoming presentations and publications, please see: https://twitter.com/Imperial_PRG

For updates about Robin Carhart-Harris' forthcoming presentations, please see: https://twitter.com/RCarhartHarris


Recruitment for upcoming trial - Psilocybin for major depression: A randomised control trial

 

Psilocybin for major depression: A randomised control trial - the design of this trial is a DB-RCT in major depressive disorder. We will use fMRI to compare the treatment mechanisms of six weeks of daily Escitalopram (SSRI antidepressant) with two doses of psilocybin. The trial commenced as of January 2019 and the team are still recruiting for participants. Please read carefully the inclusion and exclusion criteria stated below.

 It is essential that you meet these criteria:

 1)      Aged between 18-65

2)     Currently suffering from moderate to severe depression. Mild depression or historical depression are not being looked at in this study.

3)     Able to reliably attend our campus in White City London on seven occasions (requiring seven days of leave from work).

4)     Willing to take two doses of psilocybin and a six week course of Escitalopram.

 Unfortunately we cannot include you if:

 1)      You have a diagnoses of Emotionally Unstable (Borderline) personality disorder.

2)      You have a personal or immediate family history of psychosis (drug induced psychosis, Schizophrenia, Bipolar). Bipolar disorder is not being looked at in this study.

3)      You are currently addicted to alcohol or any illicit drugs. 

4)      You have taken a full course of Escitalopram in the past (please note that there is a similar medication called Citalopram which is fine to have taken).

5)      You have epilepsy or any serious heart conditions. 

Please do note that these criteria apply strictly. We would advise that you only contact us if you are confident that you meet the stated criteria. Please contact us with any questions or to apply for a telephone screening on ashleigh.murphy@imperial.ac.uk. We will endeavour to contact you as soon as we can, but please note that due to the high volume of emails coming in there may be occasional delays.

Research team

Dr Mendel Kaelen

Photo of Mendel Kaelen

Dr Mendel Kaelen
Postdoc

Dr Rosalind Watts

Photo of Rosalind Watts

Dr Rosalind Watts
Clinical Psychologist

Leor Roseman

Photo of Leor Roseman

Leor Roseman
PhD Student

Chris Timmermann

Photo of Chris Timmermann

Chris Timmermann
PhD Student

Eline Haijen

Photo of Eline Haijen

Eline Haijen
Research Associate

Bruna Giribaldi

Photo of Bruna Giribaldi

Bruna Giribaldi
Research Associate

Dr Roberta Murphy

Photo of Roberta Murphy

Dr Roberta Murphy
Psychiatrist

Dr James Rucker

Photo of James Rucker

Dr James Rucker
Psychiatrist

Dr Camilla Day

Photo of Camilla Day

Dr Camilla Day
Psychiatrist

Dr Ben Sessa

Photo of Ben Sessa

Dr Ben Sessa
Psychiatrist

Dr David Luke

Photo of David Luke

Dr David Luke
Psychologist

Luke Williams

Photo of Luke Williams

Luke Williams
Research Associate

Dr Shima Espahbodi

Photo of Dr Shima Espahbodi

Dr Shima Espahbodi
Clinical Research Scientist/Psychotherapist

Kenneth Jønck

Photo of Kenneth Jonck

Kenneth Jønck
Software architect, Psychedelic Survey Tech Lead

William Trender

William Trender

William Trender
Collaborator

Nicolai Lassen

Photo of Nicolai Lassen

Nicolai Lassen
Designer & front-end architect, Psychedelic Survey Design & Web Lead

Eduardo Schoenberg

Photo of Eduardo Schoenberg

Eduardo Schoenberg
Collaborator

Luke Gray

Photo of Luke Gray

Luke Gray
Logo design & art

Suzanne Russ

Photo of Suzanne Russ

Suzanne Russ
Collaborator

Michelle Baker-Jones

Photo of Michelle Baker-Jones

Michelle Baker-Jones
Integrative relational therapist

Laura Kartner

Photo of Laura Kartner

Laura Kartner
Intern

Hannah Douglas

Photo of Hannah Douglas

Hannah Douglas
Intern

Manca Peskar

Photo of Manca Peskar

Manca Peskar
Intern

Enzo Tagliazucchi

Photo of Enzo Tagliazucchi

Enzo Tagliazucchi
Collaborator

Dana Geerts

Photo of Dana Geerts

Dana Geerts
Intern

Sandeep Sangha

photo of Sandeep Sangha

Sandeep Sangha
Founder of Imperial Psychedelic Studies

Hannes Kettner

Photo of Hannes Kettner

Hannes Kettner
Intern

Victoria Amalie Nygart

Photo of Victoria Amalie Nygart

Victoria Amalie Nygart
Intern

Lis Marie Pommerencke

Photo of Lis Marie Pommerencke

Lis Marie Pommerencke
Intern

Melissa Shukuroglou

Photo of Melissa Shukuroglou

Melissa Shukuroglou
Research Assistant

Dr Jonny Martell

Photo of Dr Jonny Martell

Dr Jonny Martell
Study Psychiatrist

Dr Luigi Espasiano

Photo of Dr Luigi Espasiano

Dr Luigi Espasiano
Medical Doctor

Meg Spriggs

Photo of Meg Spriggs

Meg Spriggs
Post Doc